Of note, two of the studied mutations were also simultaneously identified in Helsinki: FANCD2 c.2715 + 1G > A in clinical panel sequencing of a patient with early onset triple-negative breast cancer and RNF168 c.640_644del5 in exome sequencing of hereditary breast cancer patients. This evidence concerns the gene RNF168 and breast carcinoma.